AMRN Amarin Corp PLC

Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its fourth quarter and full year 2024 results followed by Q&A on Wednesday, March 12th, 2025, at 8:00 a.m. ET.

The conference call with management will follow the release of the Company’s fourth quarter 2024 financial results in the pre-market hours on March 12th.  

Conference Call and Webcast Information:  Access to the live call: Go to the investor relations section of the Company's website at www.amarincorp.comDial in within the United States: 888-506-0062International dial in: 973-528-0011Access Code: 575561Access to replay: Dial in within the United States: 877-481-4010 International dial in: 919-882-2331  Access Code: 51859A replay of the call will also be available through the Company's website shortly after the call. 

About Amarin

Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk.   

Availability of Other Information About Amarin 

Amarin communicates with its investors and the public using the company website (www.amarincorp.com) and the investor relations website (http://www.amarincorp.com/investor-relations), including but not limited to investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin’s investor relations website and may include social media channels. The contents of Amarin’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933. 

Amarin Contact Information   Investor & Media Inquiries:Mark MarmurAmarin Corporation plcPR@amarincorp.comInvestor.relations@amarincorp.com